SCHEMBL6189901

SCHEMBL6189901

N=C(N)Cc1cccc2cccnc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.49
MMP2 P08253 2/20 0.47
TSHR P16473 2/20 0.47
CHRM1 P11229 1/20 0.47
COMT P21964 1/20 0.47
ADRA1A P35348 1/20 0.47
METAP2 P50579 1/20 0.47
METAP1 P53582 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
MAPT P10636 4/20 0.45
KDM4E B2RXH2 4/20 0.45
CYP3A4 P08684 2/20 0.45
HTT P42858 2/20 0.45
LMNA P02545 2/20 0.45
GMNN O75496 1/20 0.45
TP53 P04637 1/20 0.45
HSP90AA1 P07900 1/20 0.45
CYP2D6 P10635 1/20 0.45
MMP9 P14780 1/20 0.45
ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9181528 0.83 PARP1 (0.57) PARP1MMP2TSHRCHRM1COMT
SCHEMBL20677857 0.79 HTT (0.58) PARP1MMP2TSHRCHRM1COMT
SCHEMBL12899533 0.79 PARP1 (0.51) PARP1MMP2TSHRCHRM1COMT
SCHEMBL30553881 0.77 KDM4E (0.59) PARP1MMP2TSHRCHRM1COMT
SCHEMBL19036261 0.77 HDAC6 (0.50) PARP1MMP2TSHRCHRM1COMT
SCHEMBL9268910 0.77 MMP2 (0.48) PARP1MMP2TSHRCHRM1COMT
SCHEMBL3711541 0.77 KDM4E (0.59) PARP1MMP2TSHRCHRM1COMT
SCHEMBL9268906 0.76 HDAC6 (0.49) PARP1MMP2TSHRCHRM1COMT
SCHEMBL895544 0.76 MMP2 (0.54) PARP1MMP2TSHRCHRM1COMT
SCHEMBL30003476 0.76 TSHR (0.55) PARP1MMP2TSHRCHRM1COMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347978-B1 NOVEL SUBSTITUTED IMIDAZOTRIAZINONES AS PDE II-INHIBITORS BAYER HEALTHCARE AG (DE) 2005-08-31 EP disclosed
EP-1347978-A1 NOVEL SUBSTITUTED IMIDAZOTRIAZINONES AS PDE II-INHIBITORS Bayer Aktiengesellschaft (DE) 2003-10-01 EP disclosed
WO-2002050078-A1 NOVEL SUBSTITUTED IMIDAZOTRIAZINONES AS PDE II-INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2002-06-27 WO disclosed